¥1,463.00 ($9.28)

+20.00 (+1.39%)

Weekly Expected Move ±2.6%

¥1368 ¥1405 ¥1443 ¥1481 ¥1518

JPX · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 36 · ¥142.1B mcap · 70M float · 0.434% daily turnover

Revenue

$30.0B +5.1% ▲

5Y CAGR: +14.5%

Gross Profit

$19.3B +7.9% ▲

5Y CAGR: +14.4%

Operating Income

$8.2B -2.4% ▼

5Y CAGR: +13.5%

Net Income

$4.6B -26.1% ▼

5Y CAGR: +6.9%

EPS (Diluted)

$47.14 -26.1% ▼

5Y CAGR: +6.9%

EBITDA

$9.6B -10.6% ▼

5Y CAGR: +8.8%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$17.2B	$20.4B	$24.5B	$28.5B	$30.0B
YoY Growth	+13.1%	+18.8%	+19.9%	+16.4%	+5.1%
Cost of Revenue	$6.2B	$7.8B	$9.1B	$10.6B	$10.7B
Gross Profit	$11.0B	$12.6B	$15.4B	$17.9B	$19.3B
Gross Margin	64.0%	61.6%	63.0%	62.8%	64.5%
R&D Expenses	$1.5B	$1.6B	$2.2B	$0	$0
SG&A Expenses	$3.9B	$4.5B	$5.7B	$6.7B	$11.1B
Operating Expenses	$5.7B	$6.4B	$8.2B	$9.5B	$11.1B
Operating Income	$5.3B	$6.2B	$7.2B	$8.4B	$8.2B
Operating Margin	31.1%	30.2%	29.6%	29.4%	27.3%
Interest Expense	$1M	$2M	$2M	$6M	$3M
Income Before Tax	$6.0B	$7.4B	$8.0B	$8.4B	$7.1B
Tax Expense	$1.7B	$2.1B	$2.1B	$2.1B	$2.4B
Net Income	$4.3B	$5.3B	$6.0B	$6.3B	$4.6B
Net Margin	25.0%	25.9%	24.3%	22.0%	15.5%
EPS (Diluted)	$43.60	$53.75	$60.45	$63.82	$47.14
EBITDA	$7.5B	$9.2B	$9.9B	$10.7B	$9.6B
Shares Outstanding	98M	98M	98M	98M	98M

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$6.9B	$7.7B	$7.2B	$7.5B	$7.6B	$7.8B	$8.3B	$8.3B
Cost of Revenue	$2.6B	$2.7B	$2.7B	$2.7B	$2.7B	$2.7B	$2.7B	$2.7B
Gross Profit	$4.3B	$5.0B	$4.5B	$4.8B	$4.9B	$5.2B	$5.6B	$5.6B
Gross Margin	62.1%	65.3%	62.8%	63.7%	64.8%	65.9%	67.2%	67.0%
R&D Expenses	$583M	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$2.4B	$2.9B	$2.4B	$2.8B	$2.9B	$2.9B	$2.7B	$3.2B
Operating Expenses	$2.4B	$2.9B	$2.4B	$2.8B	$2.9B	$2.9B	$2.7B	$3.2B
Operating Income	$1.9B	$2.1B	$2.1B	$2.0B	$2.0B	$2.3B	$2.8B	$2.4B
Operating Margin	27.4%	27.5%	28.8%	26.3%	26.5%	28.8%	34.3%	28.8%
Interest Expense	$0	$1M	$0	$1M	$1M	$0	$1M	$0
Income Before Tax	$1.3B	$2.3B	$2.0B	$1.8B	$1.4B	$2.7B	$2.9B	$2.4B
Tax Expense	$95M	$707M	$622M	$439M	$295M	$807M	$931M	$675M
Net Income	$1.2B	$1.6B	$1.3B	$1.3B	$1.1B	$1.9B	$2.0B	$1.7B
Net Margin	17.4%	20.9%	18.8%	17.6%	14.7%	24.2%	24.2%	21.0%
EPS (Diluted)	$12.22	$16.23	$13.62	$13.34	$11.30	$19.25	$20.32	$17.71
EBITDA	$1.9B	$2.7B	$2.6B	$2.5B	$2.7B	$3.3B	$3.5B	$3.0B
Shares Outstanding	99M	98M	99M	99M	99M	99M	99M	99M

7730.T JPX